Kirkland Advises GTCR on Acquisition of Surmodics for Approximately $627M
May 30, 2024
May 30, 2024
CHICAGO, Illinois, May 30 -- Kirkland and Ellis, a law firm, issued the following news release:
Kirkland & Ellis represented GTCR, a leading private equity firm with a long track record of investment expertise across healthcare and healthcare technology, on its definitive agreement to acquire Surmodics, Inc., a provider of medical device and in vitro diagnostic technologies to the healthcare industry.
Under the terms of the agreement, affiliates of GTCR will acquire . . .
Kirkland & Ellis represented GTCR, a leading private equity firm with a long track record of investment expertise across healthcare and healthcare technology, on its definitive agreement to acquire Surmodics, Inc., a provider of medical device and in vitro diagnostic technologies to the healthcare industry.
Under the terms of the agreement, affiliates of GTCR will acquire . . .